source
- FDA rejects Summit, Akeso's ivonescimab in narrow lung cancer settingThe FDA rejected a new cancer treatment from Summit Therapeutics and Akeso in a decision that analysts largely expected, but ultimately shouldn’t dim the prospects for a promising class of drugs. R…Endpoints · 5m ago↗ source
- George Church departs AI startup as Ira Mellman advances immunotherapy effortsThe latest Endpoints Weekly notes that geneticist George Church has left the artificial-intelligence startup he co-founded, signaling a shift in his focus. The newsletter also highlights that immu…
- PharmaLogic acquires Lantheus radiopharma CDMO and New Jersey plant to launch transatlantic manufacturing platform